Target-specific activation of mast cells by immunoglobulin E reactive with a renal cell carcinoma-associated antigen

Laboratory Investigation

Volumn 74, Issue 2, 1996, Pages 467-475

  Luiten, R M ^a,b   Fleuren, G J ^a   Warnaar, S O ^a   Litvinov, S V ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G2B; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL SURFACE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; INFLAMMATION; KIDNEY CARCINOMA; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR GROWTH; TUMOR REGRESSION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CARCINOMA, RENAL CELL; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ISOTYPES; KIDNEY NEOPLASMS; MAST CELLS; MICE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030026003     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Aiba M, Iri H, Suzuki H, Kageyama K, Kawai T, Osahiko A, Murai M, Tazaki H, and Saruta T (1985). Numerous mast cells in an 11-deoxycorticosterone-producing adrenocortical tumor. Arch Pathol Lab Med 109:357-360.
2. Alexander RB and Rosenberg SA (1991). Tumor necrosis factor: Clinical applications. In: Devita VT, Hellman S, and Rosenberg SA, editors. Biological therapy of cancer. Philadelphia: J. B. Lippincott, 378-392.
3. Baird B, Shopes RJ, Oi VT, Erickson J, Kane P, and Holowka D (1989). Interaction of IgE with its high-affinity receptor. Structural basis and requirements for effective cross-linking. Int Arch Allergy Immunol 88:23-28.
4. Baisch H, Otto U, and Klöppel G (1990). Antiproliferative and cytotoxic effects of single and combined treatment with tumor necrosis factor α and/or α interferon on a human renal cell carcinoma xenotransplanted into nu/nu mice: Cell kinetic studies. Cancer Res 50:6389-6395.
5. Beaven MA and Metzger H (1993). Signal transduction by Fc receptors: The Fc epsilon RI case. Immunol Today 14:222-226.
6. Benhamou M, Bonnerot C, Fridman WH, and Daeron M (1990). Molecular heterogeneity of murine mast cell Fc gamma receptors. J Immunol 144:3071-3077.
7. Boot JHA, Geerts MEJ, de Groot ER, and Aarden LA (1988). Murine monoclonal isotype switch variants: Detection with rat monoclonal antibodies in ELISA and isolation by sequential sublining. J Immunol Methods 106:195-202.
8. Cawley EP and Hoch-Ligeti C (1961). Association of tissue mast cells and skin tumors. Arch Dermatol 83:146-150.
9. Collins DS, Dupuis R, Gleich GJ, Bartemes KR, Koh YY, Pollice M, Albertine KH, Fish JE, and Peters SP (1993). Immunoglobulin E-mediated increase in vascular permeability correlates with eosinophilic inflammation. Am Rev Respir Dis 147:677-683.
10. Cramer W and Simpson W (1944). Mast cells in experimental skin carcinogenesis. Cancer Res 4:601-616.
11. Daeron M, Prouvost-Danon A, and Voisin GA (1980). Mast cell membrane antigens and Fc receptors in anaphylaxis II. Functionally distinct receptors for IgG and for IgE on mouse mast cells. Cell Immunol 49:178-189.
12. Edwards DP, Grzyb KT, Dressier LG, Mansel RE, Zava DT, Sledge GW Jr, and McGuire WL (1986). Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer. Cancer Res 46:1306-1317.
13. Fiers W (1993). Tumour necrosis factor. In: Sim E, editor. The natural immune system: Humoral factors. New York: Oxford University Press, 65-119.
14. Geha RS (1992). Atopic allergy and other hypersensitivities. Editorial overview: Present and future trends in allergy. Curr Opin Immunol 4:779-781.
15. Ghaira P, Boraschi D, Villa L, Scapigliati G, Taddei C, and Tagliabue A (1985). In vitro generated mast cells express natural cytotoxicity against tumour cells. Immunology 55: 317-324.
16. Grezel D, Capron M, Grzych JM, Fontaine J, Lecocq JP, and Capron A (1993). Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: Effector mechanisms involving IgE and IgA antibodies. Eur J Immunol 23:454-460.
17. Henderson W, Chi E, Jong E, and Klebanoff S (1981). Mast cell mediated tumor cell cytotoxicity. J Exp Med 153:520-533.
18. Jadus MR, Schmunk G, Djeu JY, and Parkman R (1986). Morphology and lytic mechanisms of interleukin 3-dependent natural cytotoxic cells: Tumor necrosis factor as a possible mediator. J Immunol 137:2774-2783.
19. Lascano E (1958). Mast cells in human tumors. Cancer 11:1110-1114.
20. Lobell RB, Austen KF, and Katz HR (1994). Fc gamma R-mediated endocytosis and expression of cell surface Fc gamma RIIb1 and Fc gamma RIIb2 by mouse bone marrow culture-derived progenitor mast cells. J Immunol 152:811-818.
21. Massey WA and Lichtenstein LM (1992). Role of basophils in human allergic disease. Int Arch Allergy Immunol 99:184-188.
22. Moqbel R, MacDonald AJ, Cromwell O, and Kay AB (1990). Release of leukotriene C4 (LTC4) from human eosinophils following adherence to IgE- and IgG-coated schistosomula of Schistosoma mansoni. Immunology 69:435-442.
23. Nagy E, Berczi I, and Sehon AH (1991). Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virus. Cancer Immunol Immunother 34:63-69.
24. Ohkawara Y, Yamauchi K, Tanno Y, Tamura G, Ohtani H, Nagura H, Ohkuda K, and Takishima T (1992). Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-alpha in sensitized lung tissue after IgE triggering. Am Rev Respir Dis 7:385-392.
25. Okuno T, Takagaki Y, Pluznik DH, and Djeu JY (1986). Natural cytotoxic (NC) cell activity in basophilic cells: Release of NC-specific cytotoxic factor by IgE receptor triggering. J Immunol 136:4652-4658.
26. Oosterwijk E, Bander NH, Divgi CR, Welt S, Wakka JC, Finn RD, Carswell EA, Larson SM, Warnaar SO, Fleuren GJ, Oettgen HF, and Old LJ (1993). Antibody localization in human renal cell carcinoma: A phase I study of monoclonal antibody G250. J Clin Oncol 11:738-750.
27. Oosterwijk E, Ruiter DJ, Hoedemaeker PJ, Pauwels EKJ, Jonas U, Zwartendijk J, and Warnaar SO (1986). Monoclonal antibody G250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int J Cancer 38:489-494.
28. Paul WE, Seder RA, and Plaut M (1993). Lymphokine and cytokine production by Fc epsilon RI+ cells. Adv Immunol 53:1-29.
29. Sutton BJ and Gould HJ (1993). The human IgE network. Nature 366:421-428.
30. Tanooka H, Kitamura Y, Sado T, Tanaka K, Nagase M, and Kondo S (1982). Evidence of involvement of mast cells in tumor suppression in mice. J Natl Cancer Inst 69:1305.
31. Tharp MD, Kasper C, Thiele D, Charley MR, Kennerly DA, and Sullivan TJ (1989). Studies of connective tissue mast cell-mediated cytotoxicity. J Invest Dermatol 93:423-428.
32. Triggiani M, Casolaro V, Genovese A, Spadaro G, and Marone G (1993). Heterogeneity of human Fc epsilon RI-bearing cells. Ann Allergy 71:133-138.
33. Van Dijk J, Oosterwijk E, Kroonenburgh VJPG, Jonas U, Fleuren GJ, Pauwels EKJ, and Warnaar SO (1988). Perfusion of tumor-bearing kidneys as a model for scintigraphic screening of monoclonal antibodies. J Nucl Med 29:1078-1082.
34. Van Dijk J, Zegveld ST, Fleuren GJ, and Warnaar SO (1991). Localization of monoclonal antibody G250 and bispecific monoclonal antibody CD3/G250 in human renal-cell carcinoma xenografts: Relative effects of size and affinity. Int J Cancer 48:738-743.
35. Wershil BK, Wang ZS, Gordon JR, and Galli SJ (1991). Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. J Clin Invest 87:446-453.
36. Wlodarski K, Kukwa A, Blaton O, Dabska M, Ruben R, Borowiecki R, and Jeziorny A (1983). Decrease of mast cells in the stroma of human cancer. Arch Immunol Ther Exp (Warsz) 31:261-266.
37. Yoo D and Lessin L (1982). Mast cell content in preleukemic syndrome. Am J Med 73:539-542.
38. Yuong JDE, Liu CC, Butler G, Cohn ZA, and Galli SJ (1987). Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor. Proc Natl Acad Sci USA 84:9175-9179.